Abstract. Niche astrocytes have been reported to promote neuronal differentiation through juxtacrine signaling. However, the effects of astrocytes on neuronal differentiation following ischemic stroke are not fully understood. In the present study, transplanted astrocytes and neural stem cells (NSCs) were transplanted into the ischemic striatum of transient middle cerebral artery occlusion (MCAO) model rats 48 h following surgery. It was observed that the co-transplantation of astrocytes and NSCs resulted in a higher ratio of survival and proliferation of the transplanted NSCs, and neuronal differentiation, in MCAO rats compared with NSC transplantation alone. These results demonstrate that the co-administration of astrocytes promotes the survival and neuronal differentiation of NSCs in the ischemic brain. These results suggest that the co-transplantation of astrocytes and NSCs is more effective than NSCs alone in the production of neurons following ischemic stroke in rats.
Introduction
Strokes, a leading cause of death and disability worldwide, cause a disturbance of neuronal circuitry and disruption of the blood-brain barrier that can lead to functional disabilities (1) . Currently, there is no pharmacological intervention that can effectively improve neurological outcome in patients with stroke (2) . While conventional therapeutic strategies focus on preventing brain damage, stem cell transplantation has the potential to repair the injured brain tissue. Recently, neural stem cells (NSCs) have been developed and used in preclinical studies as therapy for stroke (3, 4) .
NSCs are undifferentiated neural cells that are multipotent and possess the capacity for self-renewal. NSCs differentiate into three cell lineages, neurons, astrocytes and oligodendrocytes (5, 6 ). An increasing number of studies highlight the potential of NSC transplantation as a novel therapeutic approach for stroke (7) (8) (9) . NSCs are primarily produced in the subventricular zone (SVZ) of the lateral ventricles and the subgranular zone (SGZ) of the hippocampus in the adult nervous system (10) . Previous studies investigating the association between NSCs and ectogenic and endogenic factors have increased the understanding of how to modulate the proliferation and differentiation of NSCs during neurogenesis (11, 12) . NSCs reside in specialized microenvironments, or 'niches', that regulate their self-renewal and differentiation activities (13) . For example, the continuous production of neuroblasts is maintained by the SVZ microenvironmental niche (3, 4) . It is widely believed that enhancing the neurogenic activities of endogenous NSCs will provide a much-needed therapeutic option for brain injuries (14) . Astrocytes are typically considered cellular components of these stem cell niches, and astrocytes isolated from postnatal (16) . NSCs transplanted together with NAs may be a novel strategy for the treatment of neural injury.
In the present study, the effect of NAs on the regulation of co-transplanted NCSs was evaluated in rat models following transient cerebral ischemia.
Materials and methods
A nimal surger y. 5 cells/ml in serum-free culture medium containing Dulbecco's modified Eagle's medium (DMEM; 1:1; Gibco; Thermo Fisher Scientific, Inc., Beijing, China). This was supplemented with 1% B-27, 1% N-2, 20 ng/ml epidermal growth factor, 20 ng/ml basic fibroblast growth factor (all Invitrogen; Thermo Fisher Scientific, Inc.), penicillin (100 units/ml) and streptomycin (0.1 mg/ml). Cultured NSCs aggregated into free-floating neurospheres and were passaged (split ratio, 1:4) by mechanical dissociation between every 6 and 7 days.
For astrocyte primary cultures, astrocytes were extracted from the cerebral cortex of P0 C57BL/6-eGFP -mice. Cells were seeded at a density of 5x10 5 cells/ml on poly-L-lysine-treated 25 cm 2 culture flasks with DMEM (1:1), supplemented with 10% fetal bovine serum (Gibco; Thermo Fischer Scientific, Inc.), 100 units/ml penicillin and 100 µg/ml streptomycin. The cells were fed with fresh media every 2-3 days and subcultured (passage ratio, 1:4) weekly. To determine the purity of the astrocytes they were labeled with nuclear dye Hoechst 33342 (20 ng/ml; Biotium, Hayward, CA, USA) and immunofluorescence staining for glial fibrillary acidic protein (GFAP) was performed (described below), in order to acquire the percentage of GFAP-positive cells among the Hoechst 33342-labeled cells. The purity of the astrocytes used for implantation in the current study was ≥95%.
Cell transplantation. Cultured NSCs and astrocytes used in the study were passaged three times prior to implantation. On the day of transplantation, NSCs and astrocytes were centrifuged at 250 x g for 5 min at 4˚C and resuspended in PBS, yielding 2x10 4 viable cells/µl. The NSC and astrocyte suspension was kept on ice throughout the surgery. MCAO rats were assigned into the following two groups (each n=12): One group was transplanted with NSCs and astrocytes; and one group transplanted with NSCs. Forty-eight h following MCAO, the cerebral ischemic rats were anesthetized with chloral hydrate and placed in a stereotactic instrument (Narishige International, Ltd., London, UK). Next, the cells were injected into the right striatum of the ischemic cerebral hemisphere (Fig. 1A) of the MCAO rats (0.5 mm anterior and 3 mm lateral from the bregma, 5 mm from the brain surface) using a microcrystal line syringe at a speed of 0.5 µl/min, with a 5 min delay prior to removal of the syringe. All surgical procedures were performed under aseptic conditions. Following cell delivery, all rats were administered a subcutaneous injection of cyclosporine A (10 mg/kg body weight; Beyotime Institute of Biotechnology, Shanghai, China) every other day. The survival of transplanted NSCs in MCAO rats was investigated 7 days following transplantation, and the proliferation and differentiation of transplanted NSCs was assessed 14 days following transplantation.
Immunofluorescence staining. Rats were sacrificed with a peritoneal injection of 10% chloral hydrate (Sigma-Aldrich), transcardially perfused with saline followed by ice-cold 4% paraformaldehyde (Wuhan Boster Biological Technology, Ltd., Wuhan, China) a for 24 h at 4˚C. Coronal sections of 30 µm were cut and processed for immunostaining, as described previously (18) . Triple-label immunofluorescence staining was performed on the sections. Following blocking, using 10% normal goat serum (Beyotime Institute of Biotechnology) for 1 h at room temperature, the following primary antibodies were added: Mouse anti-GFAP, a marker for mature astrocytes (1:500; Abcam, Cambridge, UK; cat. no. ab3670); rabbit anti-oligodendrocyte (Oli) to label oligodendrocytes (1:500, Abcam; cat no. ab53041); rabbit anti-doublecortin (Dcx) to label migrating neuroblasts (1:1,000; Cell Signaling Technology, Inc., Beverly, MA, USA; cat. no. 4604); mouse anti-neuronal nuclei (NeuN) to label mature neurons (1:500; EMD Millipore, Billerica, MA, USA; cat. no. MAB377); mouse anti-BrdU to label dividing cells Statistical analysis. The results are expressed as the mean ± the standard error of the mean. Statistical comparisons between groups were performed with one-way analysis of variance, followed by a Student's t-test using SPSS software (version 17.0; SPSS, Inc., Chicago, IL, USA). P<0.05 was considered to indicate a statistically significant difference.
Results

Niche astrocytes promote the survival and proliferation of transplanted NSCs in MCAO rats.
To study the effect of astrocytes on the survival of transplanted NSCs in MCAO rats, the transplanted NSCs were evaluated 7 days after transplantation. eGFP + cells were observed in rats that received NSCs with and without astrocytes (Fig. 1B) . The number of GFP + NSCs was significantly higher in the co-transplantation group, compared with the group receiving NSCs alone (2,588±76.88 cells/mm 2 vs. 1,836±57.41 cells/mm 2 ; P<0.01; Fig. 1C ). In the co-transplantation group an increased number of transplanted GFP + NSCs were BrdU + (Fig. 1D) (Fig. 2A) . On day 14, GFP + /NeuN + cells were observed in the striatum (Fig. 2B ). The ratio of NeuN + cells in the population of GFP + cells was evaluated, showing that there was a significantly higher level of neuronal differentiation in co-transplanted cells compared Grafted NSCs express functional proteins. To confirm whether the neonatal neurons from NSCs could help reconstruct synapses in the border of the infarction, the detection of neuronal marker proteins was performed. Results showed a subpopulation of transplanted NSCs at the lesion boundary and a number of migrating cells that could express Synapsin-1, GABA, PSD-95, MAP-2, ChAT and PGRN proteins (Fig. 3) .
Discussion
NSC transplantation therapy for strokes is promising (7, 8) . NAs, as a cellular component of the stem cell microenvironment, are reported to display regional heterogeneity in their ability to regulate neurogenesis (19) . In the present study, it is demonstrated that co-transplantation of NAs promotes the survival, proliferation and neuronal differentiation of SVZ-derived NSCs in the ischemic brain. Previous studies have reported that numerous factors can influence the efficiency of stem cell transplantation therapy (20, 21) . Consistent with previous studies, the data in the current study shows that transplantation of NSCs together with astrocytes results in markedly enhanced survival, proliferation and neuronal differentiation of NSCs, which indicates that astrocytes serve a critical role in modulating NSC fate determination (22, 23) . Astrocytes can secrete neurotrophins (nerve growth factor, ciliar y neurotrophic factor, brain-derived neutrotrophic factor and neurotrophin-3), chemokines (interleukins -4 and -6) and cytokines (leukemia inhibitory factor) under different conditions, through which it can regulate the proliferation, differentiation and migration of NSCs (24) . However, the exact signaling pathways through which astrocytes regulate the behavior of NSCs in co-transplantation conditions remains unknown. Further studies will be performed to investigate the molecular mechanism underlying the synergistic function between astrocytes and NSCs during cell transplant therapy. Nedachi et al (25) reported that PGRN could enhance neural progenitor cell proliferation. The results in the present study showed that PGRN was expressed in a number of subpopulations of grafted NSCs on day 7 and 14 following transplantation. Previous results have indicated that PGRN is abundantly expressed in neurospheres and their differentiated cell lineages (5). In the current study, antibodies against Synapsin-1, GABA, PSD-95, MAP-2 and ChAT were used, from which the results indicated that the differentiated cell lineages from grafted NSCs were involved in the ischemic brain repair.
In conclusion, the results in the present study demonstrate that NAs serve a synergistic role to promote the survival, proliferation and neuronal differentiation of NSCs in the ischemic brain. NSC transplantation together with NAs may be a novel strategy for the repair of stroke injury.
